Ironwood Pharmaceuticals (IRWD) EBITDA Margin (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted EBITDA Margin of 68.14% for Q1 2026, up 377.72% sequentially from 14.26% in Q4 2025, and up 13889.0% YoY from N/an in Q1 2025.
Ironwood Pharmaceuticals (IRWD) EBITDA Margin (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported EBITDA Margin for 17 years, with the latest figure at 68.14% in Q1 2026.
- Quarterly EBITDA Margin rose 13889.0% year-over-year to 68.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 55.37% (up 3869.0% YoY) and the FY2025 annual result came in at 33.26%, up 676.0% from the prior year.
- EBITDA Margin grew to 68.14% in Q1 2026 per IRWD's latest filing, from 14.26% in the prior quarter.
- Over five years, EBITDA Margin peaked at 68.14% in Q1 2026 and troughed at 1008.68% in Q2 2023.
- A 5-year average of 24.11% and a median of 35.19% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin plunged 106592 bps in 2023, then soared 103514 bps in 2024.
- Over 5 years, EBITDA Margin stood at 63.77% in 2022, then sank by 50 bps to 31.98% in 2023, then climbed by 9 bps to 34.78% in 2024, then slumped by 59 bps to 14.26% in 2025, then surged by 378 bps to 68.14% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 68.14%, 14.26%, and 61.84% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 667.48 Mn | 588.36 Mn | - | 70.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.16% |
| Mar 31, 2026 | 68.14% |
| Dec 31, 2025 | 14.26% |
| Sep 30, 2025 | 61.84% |
| Jun 30, 2025 | 53.17% |
| Mar 31, 2025 | -70.75% |
| Dec 31, 2024 | 34.78% |
| Sep 30, 2024 | 27.99% |
| Jun 30, 2024 | 26.46% |
| Mar 31, 2024 | 14.72% |
| Dec 31, 2023 | 31.98% |
| Sep 30, 2023 | 35.19% |
| Jun 30, 2023 | -1,008.68% |
| Mar 31, 2023 | 57.75% |
| Dec 31, 2022 | 63.77% |
| Sep 30, 2022 | 63.03% |
| Jun 30, 2022 | 57.24% |
| Mar 31, 2022 | 59.31% |
| Dec 31, 2021 | 48.32% |
| Sep 30, 2021 | 62.82% |